When the surviving sarcoma cells were xenografted into immune deficient NOD-scid IL2Rγ0 mice, cells that were originally treated in vitro by PCI of CD133-saporin displayed greatly reduced tumor initiation and growth, compared to non-treated cells or cells treated with either PDT or PCI of saporin. The gene discussed is PROM1; the disease is neoplasm.